Literature DB >> 11421537

Thyroid cancer and Graves' disease: the controversy ten years later.

E L Mazzaferri.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11421537     DOI: 10.4158/EP.6.2.221

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


× No keyword cloud information.
  6 in total

1.  Clinical implications of preoperative thyrotropin serum concentrations in patients who underwent thyroidectomy for nonfunctioning nodule(s).

Authors:  Dongju Kim; Jin-Woo Park
Journal:  J Korean Surg Soc       Date:  2013-06-26

Review 2.  Controversies in the management of Graves' disease in children.

Authors:  S A Rivkees
Journal:  J Endocrinol Invest       Date:  2016-05-06       Impact factor: 4.256

3.  Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience.

Authors:  Sang Soo Kim; Byung Joo Lee; Jin Choon Lee; Sang Heon Song; Bo Hyun Kim; Seok Man Son; In Ju Kim; Yong Ki Kim; Yang Ho Kang
Journal:  Endocrine       Date:  2010-12-14       Impact factor: 3.633

4.  Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.

Authors:  Megan Rist Haymart; Daniel John Repplinger; Glen E Leverson; Diane F Elson; Rebecca S Sippel; Juan Carlos Jaume; Herbert Chen
Journal:  J Clin Endocrinol Metab       Date:  2007-12-26       Impact factor: 5.958

5.  Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer.

Authors:  L L Cunha; R C Ferreira; M A Marcello; J Vassallo; L S Ward
Journal:  J Thyroid Res       Date:  2011-02-17

6.  Hashimoto's thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer.

Authors:  Zhi-qiang Ye; Dian-na Gu; Hong-ye Hu; Yi-li Zhou; Xiao-qu Hu; Xiao-hua Zhang
Journal:  World J Surg Oncol       Date:  2013-03-05       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.